Literature DB >> 7029167

[The value of adding an antispasmodic musculotropic agent in the treatment of painful constipation in functional colopathies with bran. Double-blind study].

J Delmont.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7029167

Source DB:  PubMed          Journal:  Med Chir Dig        ISSN: 0047-6412


× No keyword cloud information.
  6 in total

1.  Effects of pinaverium bromide and verapamil on the motility of the rat isolated colon.

Authors:  A Baumgartner; E Drack; F Halter; U Scheurer
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

Review 2.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

Review 3.  Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis.

Authors:  Lingping Zhu; Yunhui Ma; Shasha Ye; Zhiqun Shu
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-27       Impact factor: 2.629

Review 4.  Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options.

Authors:  Darren M Brenner; Brian E Lacy
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045

5.  Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis.

Authors:  Serhat Bor; Philippe Lehert; Adriana Chalbaud; Jan Tack
Journal:  Therap Adv Gastroenterol       Date:  2021-09-15       Impact factor: 4.409

6.  Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial.

Authors:  Liang Zheng; Weimin Lu; Qi Xiao; Yaoliang Lai; Heng Fan; Yuling Sun; Dawei Huang; Yuanyuan Wang; Zhen Li; Zhengyan Jiang; Xingxing Liu; Lijuan Zhang; Dongmei Zuo; Zhexing Shou; Qing Tang; Huisuo Huang; Yongqiang Yang; Zongxiang Tang; Jun Xiao
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.